leadf
logo-loader
viewAkers Biosciences, Inc.

Akers Biociences, Inc. sees great response to digital health and wellness products

Akers Biociences Inc co-founder and chief scientific director Ray Akers told Proactive that investors should focus now on its products from its digital health and wellness platform in 2017 and beyond.
The response to these has been "greater than anything I've seen in my career," he told Sarah Lowther.
"We are seeing some real possibilities for explosive growth here in areas we didn't even contemplate when we developed these tests."
It came after the group posted a 47% increase in product revenue in the first half to almost US$1.7mln, while the rise in total revenue was 15%.
"We are so excited about the improvements all across our company - in revenues, in gross margins, in shrinking losses as we approach profitability," Akers told Proactive.

Quick facts: Akers Biosciences, Inc.

Price: 15.35 USD

NASDAQ:AKR
Market: NASDAQ
Market Cap: $1.32 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Water Tower Research brings news about a company making waves in wireless...

Water Tower Research Managing Director John Roy joined Steve Darling from Proactive with news about the Company Cambium. This is a player in the wireless broadband networking sector. Roy shares with Proactive some of the new products from the company including their 60 GHz cnWave which they...

24 minutes ago

2 min read